Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.


NDAQ:APDN - Post by User

User Avatar Image
(7)
•••
  • turner20001X
Post by turner20001on Mar 04, 2024 2:56pm
62 Views
Post# 35913972

The Directors STINK!

The Directors STINK!STRONG SELL RECOMMENDATION - 600 Reasons to Sell this Dumpster Stock
261. How has this relentless dilution driven piggybank for insiders been possible?
262. As a result of APDN's 20+ years of failure and paid stock promotions, there are no credible sophisticated investors involved anymore.
263. The only shareholders you would recognize by name are typical large holders who directly replicate the NASDAQ index for their clients as passive index investors.
264. APDN is an experimental company and here’s why.
265. APDN’s technology is not tried and true. What is so disappointing is that none of APDN’s research is published in peer-reviewed journals of high repute. That's a major red flag to any well-known scientist.
266. Furthermore, to establish that your product works as claimed it MUST be replicated by other scientists without any conflict of interest.
267. Also, double blind studies are necessary to eliminate any possible bias. None of this has been done to date with APDN’s alleged “cutting-edge” technology.
268. I don't care what Hayward claims, it won't pass muster until the aforementioned are performed and the results are published.
269. Until then, this company is a high-risk experiment in progress.
270. APDN carries an enormous risk of failure that the company consistently fails to adequately address.
 
STRONG SELL RECOMMENDATION - 600 Reasons to Sell this Dumpster Stock
271. What is one of the worst things for an investor to read?
272. “We may require additional financing which may in turn require the issuance of additional shares of common stock, preferred stock or other debt or equity securities (including convertible securities) and which would dilute the ownership held by our stockholders.”
273. This is CEO Hayward’s M.O.
274. No Dr. Hayward, what you really meant to say was: “We WILL require additional financing….”
275. This is buried deep in one of APDN’s SEC filings. APDN’s Risk Disclosure in its SEC filing is extremely worrisome - "There is substantial doubt about our ability to continue as a going concern."
276. Twenty years of misdirection. Isn't it about time for new leadership?
277. It took me a real long time to figure out Hayward's scheme. It's extremely sophisticated and I have to hand it to Hayward, “You nearly pulled it off.”
278. First you have to have a good story to entice investors. This is critical. With a good story it's much easier to raise money.
279. Then you have to develop a product and it doesn't matter if it's not that good. You also should have at least a bare minimum of sales.
280. Now it’s time to beat the drums and draw the investors in! Hayward’s really good at this.

<< Previous
Bullboard Posts
Next >>